Late incidence of cancer after metronidazole use: A matched metronidazole user/nonuser study

Clinical Infectious Diseases

Volumn 26, Issue 2, 1998, Pages 384-388

  Falagas, Matthew E ^a   Walker, Alexander M ^b   Jick, Hershel ^b   Ruthazer, Robin ^b   Griffith, John ^b   Snydman, David R ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG CARCINOGENICITY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0031951026     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516306     Document Type: Article

References (29)

1. Falagas ME, Gorbach SL. Clindamycin and metronidazole. Med Clin North Am 1995;79:845-67.
2. Soll AH. Consensus conference: medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1995;275:622-9.
3. Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994;18(suppl 4):S265-72.
4. Finegold SM. Metronidazole. Ann Intern Med 1980;93:585-7.
5. Haas JF. Cancer after metronidazole [letter]. N Engl J Med 1980;302: 520.
6. Physicians' desk reference. Metronidazole. 51st ed. Oradell, New Jersey: Medical Economics, 1997:2373.
7. DeMeo M, Vanelle P, Bernadini E, et al. Evaluation of the mutagenic and genotoxic activities of 48 nitroimidazoles and related imidazole derivatives by the Ames test and the SOS chromotest. Environ Mol Mutagen 1992;19:167-81.
8. Elhardt WJ, Beaulieu BB, Goldman P. Mammalian cell toxicity and bacterial mutagenicity of nitroimidazoles. Biochem Pharmacol 1988;37: 2603-6.
9. Legator MS, Connor TH, Stoeckel M. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice. Science 1975;188:1118.
10. Mohtashamipur E, Norpoth K. Excretion of mutagens in sweat and faeces of man, and in serum, gastric juice and urine of rats after oral dosing of niridazole or metronidazole. Mutagenesis 1986;1:371-4.
11. Mitelman F, Strombeck B, Ursing B. No cytogenetic effect of metronidazole [letter]. Lancet 1980;1:1249-50.
12. Hartley-Asp B. Metronidazole: absence of mammalian cytogenicity. Scand J Infect Dis 1981;(suppl 26):72-4.
13. Davis AE, Patterson F, Crouch R. The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br J Cancer 1992;66:777-80.
14. Sloan DA, Fleiszer DM, Richards GK, Murray D, Brown RA. Increased incidence of experimental colon cancer associated with long-term metronidazole therapy. Am J Surg 1983;145:66-70.
15. Rustia M, Shubic P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst 1972;48:721.
16. Roe FJC. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic and teratogenic potential. Surgery 1989;93:158-64.
17. Roe FJC. Metronidazole: tumorigenicity studies in mice, rats, and hamsters. In: Finegold SM, McFadzean JA, Roe JFC, eds. Proceedings of the International Metronidazole Conference (Montreal). Amsterdam: Experpta Medica, 1977.
18. Weisburger JH, Horn CL. The causes of cancer. In: Holleb AI, Fink DJ, Murphy GP, eds. Clinical oncology. Atlanta: The American Cancer Society, 1991:80-8.
19. Beard CM, Noller KL, O'Fallon WM, Kurland LT, Dockerty MB. Lack of evidence for cancer due to use of metronidazole. N Engl J Med 1979; 301:519-22.
20. Beard CM, Noller KL, O'Fallon WM, et al. Cancer after exposure to metronidazole. Mayo Clin Proc 1988;63:147.
21. Friedman GD. Cancer after metronidazole [letter]. N Engl J Med 1980; 302:519.
22. Friedman GD, Selby JV. Metronidazole and cancer [letter]. JAMA 1989; 261:866.
23. Van Den Eeden SK, Friedman GD. Prescription drug screening for subsequent carcinogenicity. Pharmacoepidemiol Drug Saf 1995;4: 275-87.
24. Danielson DA, Hannan MT, Jick H. Metronidazole and cancer [letter]. JAMA 1982;247:2498.
25. Danielson DA, Jick H, Hunter JR, Stergachis A, Madsen S. Nonestrogenic drugs and breast cancer. Am J Epidemiol 1982;116:329-32.
26. Jick H, Watkins RN, Hunter JR, et al. Replacement estrogens and endometrial cancer. N Engl J Med 1979;300:218-22.
27. Jick H, Walker AM, Watkins RN, et al. Oral contraceptives and breast cancer. Am J Epidemiol 1980;112:577-85.
28. SAS/STAT user's guide. Version 6. 4th ed. Cary, North Carolina: SAS Institute, 1990.
29. Krause JR, Ayuyang HQ, Ellis LD. Occurrence of three cases of carcinoma in individuals with Crohn's disease treated with metronidazole. Am J Gastroenterol 1985;80:978.